Using TNMplot, an integrated database of available transcriptome-level datasets enabling the comparison of normal, tumor, and metastatic data across all genes [56], we observed that DMT1 gene expression was significantly decreased in metastatic tissue compared to primary tumor in breast cancer patient samples as well as in esophageal and prostate cancer. The gene discussed is SLC11A2; the disease is breast cancer.